About Shumway Capital
Shumway Capital is a private equity firm founded in 2001. It is primarily based in Greenwich, United States.
Overall Shumway Capital portfolio has seen 2 unicorns, 6 IPOs and 8 acquisitions including key companies like Uber, Facebook and Alibaba. A lot of funds co-invest with Shumway Capital, with names like Man Capital sharing a substantial percentage of its portfolio.
Shumway Capital has a team of 6 people, including 1 partner.
Key Metrics
Shumway Capital's Portfolio
They have invested in a total of 23 companies. Their most recent investment was in Elligo (Series E round) on Sep 23, 2021. Here is the most recent investment by Shumway Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 23, 2021 | Series E | 2221 | ||
Jul 21, 2021 | Series D | 7282 | ||
Sep 17, 2020 | Series D | 9648 | ||
Jul 19, 2019 | Series C | 9055 | and 6 others |
Here is the portfolio snapshot of Shumway Capital:
Investments by Year
The maximum number of investments were made in 2019
Team profile of Shumway Capital
Shumway Capital has a team of 6 members including 1 Partner and 2 Principals located in United States. Shumway Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Shumway Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Southport | - | - | |
Principal | Greenwich | - | ||
Principal | New York City | - | ||
Associate | New York City | - | ||
Associate | United States | - |
Co-investors of Shumway Capital
Over the past 25 years, 25 investors have co-invested in Shumway Capital's portfolio companies.
- Top Co-investors of Shumway Capital: 25 investors entered a company along with Shumway Capital. These include investors like Man Capital (2 companies).
Shumway Capital News
•
With $135M in the bank, Elligo taps new buyout to build out its digital R&D platformsFierce Biotech•Sep 27, 2021•Elligo, Morgan Stanley, Ally Bridge Group, Norwest Venture Partners and 9 others
•
Morgan Stanley Expansion Capital and Ally Bridge Group Lead $135 Million Investment in ElligoBusiness Wire•Sep 23, 2021•Elligo, Morgan Stanley, Ally Bridge Group, Norwest Venture Partners and 6 others
•
Vedanta Biosciences Completes $68 Million Series D FinancingBusiness Wire•Jul 21, 2021•Vedanta Biosciences, Magnetar, Verition Fund Management, Fosun Pharmaceutical and 10 others
•
Finch Therapeutics Raises $90M in Series D FinancingFinSMEs•Sep 17, 2020•Finch Therapeutics, Willett Advisors, TPTF, SIG SAUER and 12 others
•
Vedanta Biosciences Announces $16.6 Million Series C-2 FinancingBusiness Wire•Sep 23, 2019•Vedanta Biosciences, QUAD, Shinhan Financial Group, Partners Group and 13 others
•
Clinical Stage Therapeutics Group Raises $53MLaw360•Aug 22, 2019•Finch Therapeutics, OCV Partners, SIG, Symbiosis and 5 others
•
Vedanta Biosciences Closes Extended $45.5 Million Series C FinancingBusiness Wire•May 13, 2019•Vedanta Biosciences, JSR Corporation, Shumway Capital, symbiosislife.com and 10 others
•
Elligo Health Research Raises $20M to Connect More Physicians and Their Patients to Clinical Research as a Care OptionBusiness Wire•May 07, 2019•Elligo, Piper Sandler, Piper Jaffray, Hatteras Venture Partners and 6 others
•
Elligo Health Research Raises $16M to Improve Access to Clinical TrialsBiotechFinances•Mar 20, 2018•Elligo, Hatteras Venture Partners, Noro-Moseley Partners, First Stop Health and 3 others
•
Finch Therapeutics Group Raises $36 Million In Series B FinancingReuters•Mar 01, 2018•Finch Therapeutics, Shumway Capital, Willett Advisors, Morgan Noble and 1 other
